Blog

Insights That Drive Impact

Explore how integrated pharmacy solutions can enhance care, optimize spending, and strengthen communities. Our resources and expert guidance are crafted to help hospitals, plans, and partners lead with clarity, compassion, and impactful results.

View All
Blog
News

Blog

Understanding Chronic Kidney Disease and Its Impact on Hispanic Communities

Over 35 million Americans have chronic kidney disease (CKD). Some populations are at higher risk for developing CKD, including Hispanics. Currently, about 14% of Hispanics ...

Blog

Remote Patient Monitoring: An Overview

Using digital devices to monitor patients’ health is known as remote patient monitoring (RPM). RPM is a type of telehealth, and patients and providers don’t ...

Blog

Beyond Diabetes and Obesity: The Expansion of GLP-1 Medications

Glucagon-like peptide-1 (GLP-1) medications have revolutionized the treatment of diabetes and obesity, but their impact is rapidly broadening. Recent research and regulatory approvals reveal that ...

News

VytlOne and Maury Regional Health Expand Their Pharmacy Services Partnership

VytlOne, a leading provider of pharmacy solutions, is expanding its existing partnership with Maury Regional Health—a 255-bed, not-for-profit, vertically integrated health system that operates hospitals ...

Blog

The rise of long-acting injectable drugs: Changing the way we manage chronic disease

Overview In the ever-evolving world of healthcare, long-acting injectable drugs (commonly known as LAIs) are making significant waves. These medicines, administered through injections, are designed ...

News

Big news! Maxor is now VytlOne

Maxor Rebrands as VytlOne to Highlight Its Innovative Full-Service Pharmacy Solutions That Drive Revenue, Growth, and Better Outcomes Maxor National Pharmacy Services (“Maxor”) today announced ...

Blog

Rx to OTC: 5 drugs that went from prescription to over-the-counter

Are you curious about how some medicines, once available only by prescription, end up on your local pharmacy shelves for anyone to purchase? The U.S. ...

Blog

VytlOne and Maury Regional Health Expand Their Pharmacy Services Partnership

Blog

Drug shortages: Q3 2025 Update

As of July 1, 226 active drug shortages are affecting the U.S. healthcare system, according to the American Society of Health-System Pharmacists (ASHP). While this ...

Blog

Navigating Pharmacy Benefits Effectively

Learn how to optimize your pharmacy benefits for better outcomes.

Blog

How Recent 340B Changes Impact Specialty Pharmacies In 2025

The evolving legal and legislative landscape surrounding the 340B Drug Pricing Program has significant implications for hospitals’ specialty pharmacies. Here’s a breakdown of the new developments and ...

Blog

The Compliance Arms Race: Can Smaller Entities Keep Up?

by Abel Haile, Senior Director of Health System Strategy & Commercial Analytics, VytlOne How smaller entities can survive and thrive Overview The 340B program has ...

Blog

Expanding access: How the 340B program helps Ryan White clinics

Understanding the impact of 340B and RWHAP on HIV Care What is the Ryan White HIV/AIDS Program? The Ryan White HIV/AIDS Program (RWHAP), established in ...

Blog

Bridging the gap between limited distribution drug manufacturers and patients

Overview Specialty pharmacy excellence We hold the URAC Specialty Pharmacy certification with Rare Disease Pharmacy Center of Excellence designation. Our team provides exceptional holistic care ...

Blog

Polypharmacy Management 101

Polypharmacy is the regular use of five or more medications at the same time. Polypharmacy is associated with more hospitalizations and higher care costs for ...

Blog

Big news! Maxor is now VytlOne

Blog

Building a comprehensive 340B strategy

The 340B Drug Pricing Program, established by Congress in 1992, was designed to help eligible healthcare organizations stretch scarce federal resources in order to serve ...

Blog

Too far to fill: The growing problem of pharmacy deserts in America

Equity in healthcare series – part 9 Millions of Americans now live in areas with limited or no access to pharmacies, revealing a growing health ...

Blog

Mental health in rural America: Barriers to care

Equity in healthcare series – part 8 Mental health has been gaining attention in recent years, but for many Americans living in rural communities, access ...

Blog

Five ways AI can improve medication adherence

Join us for the latest in our series, AI in healthcare. Learn how AI is transforming the way we track, predict, and promote medication adherence. ...

Blog

Stretching Scarce Federal Resources: How Conway Medical Center Is Redefining 340B’s Impact

by Howard Hall, SVP Enterprise Growth, Maxor The purpose of the 340B Drug Pricing Program continues to spark debate, particularly between covered entities (CEs) and ...

Blog

Uncovering health disparities in Asian American and Pacific Islander communities

Equity in healthcare series – part 7 May marks Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Heritage Month—a time to honor the diversity, resilience, ...

Blog

Exploring underrepresentation in clinical trials

Equity in healthcare series – part 6 Clinical trials are essential to advancing medical knowledge and improving patient outcomes. According to the National Institutes of ...

Blog

Drug shortage update: How 2025’s drug supply chain is evolving

Drug shortages remain a significant issue in the United States in 2025. As of April 17, there are 270 active drug shortages, according to the ...

Blog

A shift in language: How healthcare is tackling stigma

Equity in healthcare series – part 5 The words we use matter—especially in healthcare. Language shapes perceptions, influences behavior, and can either reinforce or reduce ...

Blog

A closer look at autoimmune disease

Autoimmune diseases occur when the immune system—which normally defends the body against illness—mistakenly attacks healthy cells, tissues, or organs. This can lead to chronic inflammation, ...

Blog

The future of 340B: What health system leaders need to know in 2025 and beyond

As the 340B program faces unprecedented pressure from legislators, manufacturers, and courts, health system leaders must prepare for a new era of increased scrutiny, legal ...

Blog

A look at more common rare diseases in the U.S.

When we hear the word “rare,” we might think of something uncommon or unlikely to happen. But in the world of healthcare, a rare disease ...

Blog

Women and autoimmune diseases: Understanding causes, trends, and treatments

Equity in healthcare series – part 4 Introduction Autoimmune diseases occur when the immune system malfunctions and mistakenly attacks the body’s healthy cells, tissues, and ...

Blog

What’s in a name? An overview of the drug naming process

Introduction In the U.S., drugs have three types of names: chemical, generic, and brand. Here’s how each is determined. Chemical name A drug’s chemical name ...

Blog

Women and migraines: Understanding the impact, triggers, and treatment

Equity in healthcare series – part 3 Introduction Migraines are a debilitating neurological condition that disproportionately affects women. These recurring headaches cause severe throbbing pain, ...

Blog

The vital role of caregivers in specialty pharmacy

Caregivers play a crucial role in specialty pharmacy, acting as a bridge between patients, medical staff, and pharmacists. Their responsibilities vary based on the patient’s ...

Blog

Rare disease day: A closer look at rare diseases

When we hear the word “rare,” we might think of something uncommon or unlikely to happen. But in the world of healthcare, a rare disease ...

Blog

Prescription access liaisons: Flexible support for enhanced patient care

A prescription access liaison (PAL) is a healthcare professional who can perform a variety of roles within the pharmacy, but most importantly bridges the gap ...

Blog

How to align 340B with value-based care: A framework for success

Written by William Riley, VP, Commercial Analytics, and featured in the 340B Report The healthcare system is undergoing a major transformation, with a growing emphasis ...

Blog

Use AI to transform your health system’s specialty pharmacy

Join us for the latest in our series, AI in healthcare. Learn how AI can make a positive impact on different areas of pharmacy. Written ...

Blog

The power of choice: How Maxor and ProxsysRx help you capture savings and improve patient care

As a health system, you are more than just an employer—you are a provider of care. Every decision you make impacts your patients, employees, and ...

Blog

Understanding the disparities: Why Black Americans suffer from higher rates of diabetes

Disparities in U.S. healthcare – part 2 Introduction Diabetes is a chronic health condition that affects millions of people worldwide, but it disproportionately affects Black ...

Blog

Unlocking your pharmacy’s value: Overcoming financial and manufacturer pressures

Health systems face mounting pressures across the board Health systems—especially regional ones—are under immense pressure. They struggle with staffing shortages, manufacturer restrictions on 340B, and ...

Blog

Specialty drug spend spotlight: Oncology

Oncology treatments are driving the drug pipeline Oncology therapies continue to drive a major part of the 2025 pipeline, evidenced by the 10 products that ...

Blog

What is sickle cell disease?

Racial disparities in U.S. healthcare – part 1 Outline In this blog, we will cover: Introduction Certain diseases disproportionately affect specific racial groups due to ...

Blog

The current state of U.S. drug shortages

Drug shortages in the United States have become increasingly prevalent and remain a critical issue. In the first quarter of 2024, the number of drugs ...

Blog

Specialty drug spend spotlight: CID

The Rising Costs of Chronic Inflammatory Disease Treatments The increase in chronic inflammatory disease (CID) costs has been primarily driven by tumor necrosis factor inhibitors ...

Blog

Traditional drug spend spotlight: Diabetes

Diabetes tops the list of highest traditional drug spend. Diabetes spend is predominantly driven by glucagon-like peptide-1 (GLP-1) utilization, which is projected to grow over 350% by 2027. ...

Blog

MaxorPlus Formulary Update: Stelara® Biosimilar

Last updated: May 7, 2025 Our formulary list is changing this year. We are moving to a biosimilar for Stelara®, a frequently prescribed medication for ...

Blog

Use AI to optimize your health system’s 340B program

Join us for our new series, AI in healthcare. Learn how AI can make a positive impact on different areas of pharmacy. Written by William ...

Blog

2024 drug approvals, breakthroughs, and trends

The Food and Drug Administration (FDA) approved 50 novel drugs in 2024, 5 less than the amount approved in 2023. March and December were the ...

Blog

A look forward: Outlook and insights for health systems in 2025

As we step into 2025, health systems are at a pivotal juncture with innovation and adaptability shaping their future. Here are key trends and insights ...

Blog

A look forward: Five trends PBMs should expect in 2025

As 2025 begins, PBMs should not be surprised to see many of the same trends they encountered last year. What’s ahead for PBMs? 5. More ...

Blog

GLP-1 Trends

GLP-1 agonists have become increasingly popular as a treatment option for type 2 diabetes and obesity. These medications continue to dominate the market for traditional ...

Blog

A look back: The 3 biggest trends and changes affecting health systems in 2024

In 2024, health systems across the United States navigated a year of significant transformation. Key challenges included heightened scrutiny of the 340B Drug Pricing Program, ...

Blog

A look back: Top 5 PBM 2024 market trends

It has been a year of rapid growth for pharmacy benefit managers (PBMs). Take a look at our recap of the top 5 PBM trends ...

Blog

Managing prescription spend: Introducing Maxor’s PMPM guarantees

PMPM guarantees are now available at Maxor. Small employer groups don’t have a lot of leeway when it comes to pharmacy benefit costs. Maxor’s PMPM ...

Blog

Pharmacy deserts: A growing problem in the U.S.

In the United States, 15.8 million people live in pharmacy deserts — areas with limited or no access to a pharmacy. These can exist in ...

Blog

Prepare for peak RSV season

December marks the start of peak respiratory syncytial virus (RSV) season, which typically lasts through February in most parts of the U.S. RSV is a ...

Blog

How does 340B impact specialty pharmacy?

The 340B program is a major focal point in the pharmaceutical industry, impacting specialty pharmacies, covered entities (CEs), and manufacturers as they navigate a complex ...

Blog

Biosimilar Trends

Biosimilars represent both a significant opportunity and challenge for the biopharmaceutical industry. Download our trend report to learn more about biosimilars and how Maxor’s strategy ...

Blog

Advances in Diabetes Treatment

In the United States, over 38 million people—roughly 1 in 10 Americans—are living with diabetes, a condition that impacts how the body processes blood sugar ...

Blog

Social Determinants of Health (SDOH) and Their Impact on Breast Cancer Medication Adherence

Maxor recently conducted a retrospective analysis of claims data to understand the impact of social determinants of health (SDOH) on adherence to CDK 4/6 inhibitors, ...

Blog

4 Tips to Protect Your 340B Program Benefits

As a covered entity, you must protect your 340B program from manufacturers attempting to reduce savings and eligibility. Here are four proactive steps you can ...

Blog

Cell and Gene Therapy

As the field of cell and gene therapy advances, new opportunities will emerge for healthcare stakeholders, including payers, providers, and patients. Learn about MaxorPlus’ 4-pronged ...

Blog

A day in the life: Callen-Lorde Pharmacy

It’s 8:30 am on a late September day at the Callen-Lorde pharmacy in the Chelsea neighborhood of Manhattan. Staff meet for the weekly huddle, which ...

Blog

Is your hospital still operating pharmacy as a cost center? Time to update that old approach.

As a pharmacist and executive pharmacy leader, I nodded in agreement when reading McKinsey & Company describe pharmacy services as a critical source of value ...

Blog

One size does not fit all: GLP-1 weight loss coverage options for three companies

In the United States, 39.6% of adults live with obesity.[1] Glucagon-like peptide-1 (GLP-1) agonists, often used to treat diabetes, heart conditions, and other chronic conditions, ...

Blog

New Research Reveals More Hospital and Health System C-Suites are Transforming Pharmacy Services in the Next 3-5 years

Leaders say they are turning the cost centers into revenue streams A newly released industry survey report from Maxor, a leading pharmacy solutions company, finds ...

Blog

MaxorPlus Formulary Update: Biosimilars

We are changing our formulary list for 2025, moving to a biosimilar for a frequently prescribed medication, Humira®. This switch is part of our overall ...

Blog

Nothing to cry about: Exploring the latest treatments for dry eye disease

Dry eye disease (DED) is a common medical condition, and according to the National Eye Institute, it affects about 16 million Americans, including women, people ...

Blog

MaxorPlus Named Top Workplace for Fourth Year in a Row

Maxor proudly announces that its pharmacy benefit management division, MaxorPlus, has been honored with the Top Workplaces 2024 award by Arizona Top Workplaces for the ...

Blog

Drug Spotlight – July 2024

Introducing our Drug Pipeline Spotlight We’ve highlighted three groundbreaking drugs recently approved or pending approval from the FDA. Want to learn more about partnering with ...

Blog

A big Pride Month thank you

We want to extend a big thank you to all the healthcare workers who tirelessly dedicate themselves to the care and well-being of the LGBTQ+ ...

Blog

Realizing the Value of Pharmacy with an Integrated Pharmacy Strategy

Many organizations fail to incorporate a holistic approach to pharmacy and typically will separate pharmacy benefit management from pharmacy operations management. However, creating an integrated ...

Blog

Digital Programs to Enhance Patient Care

At Maxor, we take pride in our comprehensive approach to healthcare. Our pharmacy services, benefit management solutions, and specialty pharmacy offerings utilize cutting-edge digital program ...

Blog

Topic #5: Navigating Requirements and Earning Accreditations.

In this five-part blog series, we explore the top challenges community health centers face when running profitable, efficient, and impactful in-house pharmacies. In this final ...

Blog

Maxor appoints three new executives to its executive leadership team

Plano, TX — January 3, 2024 — Maxor National Pharmacy Services (“Maxor”) today announced the appointment of three new executives. Mark McCullough joins Maxor as ...

Blog

Laying the Foundation for an Innovative 2024 in Pharmacy Benefit Management

Reflecting on 2023 As we look back on 2023, the pharmacy benefit market experienced dramatic changes. With the launch of Humira biosimilars to the market, ...

Blog

Topics #3 and #4 : Staff shortages and collaborative practice agreements.

In this five-part blog series, we explore the top challenges that community health centers face when running profitable, efficient, and impactful in-house pharmacies. In these ...

Blog

Topic #2: Ensuring Favorable Contracting

In this five-part blog series, we explore the top challenges that community health centers face when running profitable, efficient, and impactful in-house pharmacies. In Blog ...

Blog

Topic #1: Managing inventory and drug costs:

In this five-part blog series, we explore the top challenges that community health centers face when running profitable, efficient, and impactful in-house pharmacies. In Blog ...

Blog

Three Years and Counting…

We are excited to share that MaxorPlus has won the Top Workplace Award for the 3rd year in a row! This award recognizes organizations across ...

Blog

COVID-19 Updates: October 13th, 2023

On September 11th, 2023, the U.S. Food and Drug Administration approved and authorized the emergency use of an updated COVID-19 vaccine formulated to closely target ...

Blog

From Challenges to Opportunities: July 2023 Summer Coalition Conference, “Empowering 340B Programs with Maxor’s Solutions”

Who Gathered at the 340B Coalition’s Summer Conference—and Why? The July 2023 Summer Coalition Conference provided a comprehensive overview of the 340B program’s challenges and ...

Blog

Blog

Insights That Drive Impact

Login / Register

Company

Resources

Learn how we can help you